MMJ Recs

MARCH 14, 2024

Moreover, dispensaries must implement robust security measures to prevent theft and ensure patient safety. Once registered, patients gain legal access to dispensaries across the state and are protected from prosecution for possessing and using medical marijuana in accordance with state law.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Cannabis Law Report

AUGUST 10, 2021

–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. MONROVIA, Calif.–(BUSINESS CEO and Co-Founder of PSI Labs. “PSI

Research and Development 105

Research and Development Compliance Compliance Safety 105

Cannabis Law Report

JULY 23, 2021

Position Summary: Reporting to Operations Manager, the Cannabis & Controlled Substances Officer (CCBO) will inspect various teaching, diagnostic and research facilities of the University. Provide advice and safety training sessions to the community on safe handling, use and disposal of cannabis and/or controlled substances.

Research and Development 105

Research and Development Safety Compliance Compliance 105

Cannabis Law Report

FEBRUARY 13, 2022

of the NYS Civil Service Law. Reporting to a Program Specialist 3 (Cannabis), the Program Specialist 2 (Cannabis) positions will be responsible for overseeing and participating in inspecting, auditing, and performing a full range of compliance duties for the region assigned (Albany/Buffalo/NYC).

Programs 52

Programs Research and Development Seed-To-Sale Compliance 52

Cannabis Law Report

FEBRUARY 3, 2022

Michigan-Based Cannabis Lab Grows Its Team, Continues Advocating for Consumer Safety and Industry Transparency. PSI Labs’ increased service line will offer more environmental testing as well as research and development. ANN ARBOR, Mich.–(BUSINESS CEO and Co-Founder of PSI Labs. “The About PSI Labs. Andre Hascall.

Research and Development 52

Research and Development Safety Advocacy Compliance 52

Cannabis Law Report

JULY 20, 2021

Compliance Division – Richard Parrott. Elliott was the Governor’s Senior Advisor on Cannabis at the Governor’s Office of Business and Economic Development. Salama was Assistant Branch Chief of the California Department of Public Health’s Manufactured Cannabis Safety Branch. Compliance Division – Richard Parrott.

Research and Development 105

Research and Development Compliance Compliance Food 105

MMJ Recs

JANUARY 2, 2024

As scientific research delves deeper into medical cannabis for cancer patients, MMJ’s potential has come to the forefront, offering new hope for individuals grappling with the complexities of cancer. From their interactions with the endocannabinoid system to potential anti-cancer mechanisms, ongoing research is unraveling the complexities.

Treatment 98

Treatment Therapy Research and Development Patients 98

MMJ Recs

MARCH 20, 2024

Furthermore, changes to testing and labeling requirements aim to uphold product quality and safety standards, providing patients with confidence in the products they receive from licensed dispensaries. Recent developments include the expansion of cultivation facilities, processing centers, and dispensaries to meet growing patient demand.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JULY 14, 2021

The 12-person commission studies cannabis-related issues and makes recommendations on regulations and other industry-related issues to the Nevada Cannabis Compliance Board (CCB). Public Safety: To review and make recommendations on matters related to the effects of cannabis on law enforcement, businesses, and consumers.

Compliance 102

Compliance Compliance Research and Development Safety 102

MMJ Recs

FEBRUARY 21, 2024

Through an examination of existing research and anecdotal evidence, we aim to provide a closer look at the potential effects of medical marijuana on women’s health. Research suggests that cannabinoids may have anti-inflammatory and analgesic effects, potentially aiding in symptom relief.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Led by Dr. After a close analysis of the data, the team determined that an absence of consistent federal guidelines regarding marijuana contaminants ultimately increases the risk of consumers developing health issues. Their research led them to discover that 5.1%

Research and Development 92

Research and Development Agriculture Data Extraction 92

Cannabis Law Report

AUGUST 11, 2021

HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. With a strong focus on research and development, HempFusion has an additional 30 products under development.

Research and Development 105

Research and Development Tincture Food Hemp 105

Cannabis Law Report

JUNE 11, 2021

This position will assist the enforcement units in implementing consistent regulatory compliance measures for the Commonwealth’s marijuana industry. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. 30A; and.

Research and Development 90

Research and Development Compliance Compliance Packaging 90

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Dykema (Cannabis Law Blog)

AUGUST 5, 2020

The new law creates a regulatory scheme for industrial hemp that should allow Michigan to obtain approval from the United States Department of Agriculture (“USDA”) of its plan to administer an industrial hemp program under the 2018 Farm Bill. However, these rules largely incorporate by reference the requirements provided in IHRDA.

Hemp 40

Hemp Programs Law Research and Development 40

Cannabis Law Report

NOVEMBER 6, 2021

This position will assist the enforcement units in implementing consistent regulatory compliance measures for the Commonwealth’s marijuana industry. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. 30A; and.

Research and Development 52

Research and Development Compliance Compliance Packaging 52

Cannabis Law Report

OCTOBER 21, 2021

A new nationwide study commissioned by SICPA North America, a leading provider of regulatory compliance solutions, and conducted online by The Harris Poll among over 2,000 U.S. adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

JULY 1, 2022

We are currently recruiting for a Program Analyst to develop, coordinate, and analyze our tracking systems. The position will be developing and evaluating OPS’s Training program, Licensing and Compliance (TLC) system as well as OPS’s product tracking system. Research and recommend systems, policies, and operations.

Programs 52

Programs Compliance Compliance Research and Development 52

MMJ Recs

MARCH 23, 2024

Additionally, legalization may lead to increased research opportunities into the therapeutic properties of cannabis, potentially uncovering new medical uses and treatment modalities. However, challenges such as regulatory compliance costs and market saturation may affect the profitability of cannabis businesses.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

NOVEMBER 19, 2021

“These patent filings are critical components of PsyBio’s corporate development strategy. “These patent filings are critical components of PsyBio’s corporate development strategy. PsyBio remains interested in developing the intellectual property landscape within the psycho-targeted development drug arena.

Clinical Trials 52

Clinical Trials Research and Development Events Safety 52

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 26, 2021

Review product conformance and assure compliance. Working closely with marketing, R&D and product development team to streamline product registration to the distribution process. Develop and conduct programs to maintain quality standards of raw materials and finished products. REQUIREMENTS: B.Sc

Compliance 52

Compliance Compliance Research and Development Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 28, 2021

KindTap’s digital credit solution will allow consumers to pay for cannabis through a pre-approved credit line using the KindTap web-based application in-store or online, providing improved efficiency, safety and security on both sides of the transaction while encouraging a larger basket size per purchase.

Banking 52

Banking Research and Development Retail Compliance 52

Cannabis Law Report

JUNE 24, 2021

production of cannabis for medicinal purposes or research related to medicinal cannabis. As the industry is maturing, MCS is developing its compliance team that undertakes. monitoring and compliance activities, including inspections, to ensure licence holders are in. compliance with the associated legislation.

Environment 80

Environment Research and Development Safety Compliance 80

Cannabis Law Report

JULY 14, 2021

The research we completed is exploratory but the results are consistent with our earlier research. ImmunoFlex has submitted non-provisional ( USA ) and PCT (international) patent applications based on the research carried out by ImmunoFlex in 2020 and 2021. We look forward to the next chapters in their development”.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

SEPTEMBER 1, 2021

This milestone speaks to the success of licensees that have interacted with the Commission from the application stage, maintained compliance with our strict regulations, and contribute every day to communities across the Commonwealth. Public Health, Safety, and Other Administrative Updates. million for the full calendar year of 2019.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JANUARY 27, 2022

Our strict adherence to legal compliance and transparency make Delta Extrax one of the most trusted and desirable brands on the market. All products are third-party lab tested to certify quality, safety, purity and authenticity.

Hemp 52

Hemp Tincture Research and Development Pets 52

Cannabis Law Report

MAY 12, 2022

The Associate General Counsel, under the direction of the General Counsel, will support the Commission’s mission and its staff, and will address and resolve legal matters in settled and evolving areas of the law. The safety of our employees, both current and future, is the Commission’s highest priority.

Research and Development 52

Research and Development Packaging Compliance Compliance 52

Cannabis Law Report

MARCH 26, 2022

With five guiding objectives, the commission will reportedly consider the UK’s cannabis industry’s entire supply chain from cultivation, research and development to product development and manufacturing and sales. The final report will outline how the UK can become a global leader in cannabinoid research and innovation.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. The state has developed a comprehensive set of laws to regulate the cultivation, distribution, and use of medical marijuana.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JANUARY 24, 2022

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Edwin (Ed) Tucker, M.D., Tucker has successfully advanced several programs through clinical development and regulatory approval.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

NOVEMBER 6, 2019

We strive to conduct business openly and transparently, leverage state-of-the-art technology, foster a great place to work, develop and enforce effective regulations, educate the public, and conduct robust research. . . On each of these fronts, we are proud to share the work we have accomplished to date.

Research and Development 45

Research and Development Programs Education Compliance 45

Cannabis Law Report

AUGUST 3, 2021

HempFusion’s substantial investment into regulatory compliance will help solidify Apothecanna’s leadership position in the CBD industry. With a strong focus on research and development, HempFusion has an additional 30 products under development.

Research and Development 105

Research and Development Topical Events Compliance 105

Cannabis Law Report

SEPTEMBER 19, 2019

The Notice cites the Company’s previous non-compliance with certain requirements of the Cannabis Act ( Canada ) and the regulation made thereunder (the “Cannabis regulations”) in respect of the matters that the Company has been discussing with Health Canada. The Company remains committed to being in full regulatory compliance.

Compliance 55

Compliance Compliance Events Research and Development 55

Cannabis Law Report

SEPTEMBER 17, 2021

The three-and-a-half year pilot scheme announced on Tuesday, takes advantage of a change in the law that was approved by parliament last year. The effects of regulated cannabis use are being researched in a three-and-a-half year study. Consumers of cannabis products will also be limited to protect health, public safety and minors.

Recreational 52

Recreational Research and Development Consumption Safety 52

Cannabis Law Report

JANUARY 12, 2022

Today, HempFusion and its family of brands are one of the select few CBD companies that stand fully prepared to meet or exceed US & global compliance standards. It’s a common misconception in the industry that when one company achieves this level of compliance, it applies to all other companies.

Retail 52

Retail CBD Extraction Research and Development 52